Open access
Open access
Powered by Google Translator Translator

Hematology

Observational Study: Many Patients with Covid-19 in the UCI Develop Thromboembolism Despite Routine Prophylaxis

29 May, 2020 | 03:17h | UTC

Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019 – Critical Care Medicine

 


Meta-Analysis: Direct Oral Anticoagulants vs. Low‐molecular‐weight Heparin for the Treatment of Cancer‐associated Thrombosis

29 May, 2020 | 03:03h | UTC

Direct oral anticoagulants compared to low‐molecular‐weight heparin for the treatment of cancer‐associated thrombosis: Updated systematic review and meta‐analysis of randomized controlled trials – Research and Practice in Thrombosis and Haemostasis

“In patients with cancer‐associated VTE, DOACs are more effective in preventing recurrent VTE compared to LMWH. However, risk of bleeding is increased with DOACs, especially in patients with GI cancer.”

 


Meta-analysis: Efficacy and Safety of Convalescent Plasma for Severe COVID-19

27 May, 2020 | 02:21h | UTC

Efficacy and safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infections: a systematic review and meta-analysis – Canadian Medical Association Journal

 


Clinical Guidance: Thromboembolism and Anticoagulant Therapy During the COVID-19 Pandemic

25 May, 2020 | 01:43h | UTC

Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum – Journal of Thrombosis and Thrombolysis

Related: Coagulation abnormalities and thrombosis in patients with COVID-19 – The Lancet AND COVID-19 and its implications for thrombosis and anticoagulation – Blood AND Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines – Thrombosis and Haemostasis AND Thrombosis and COVID-19: FAQs For Current Practice – American College of Cardiology

 


Hemostasis Disorders in Critically Ill Patients with COVID-19

18 May, 2020 | 02:08h | UTC

Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19 – Intensive Care Medicine

 

Related Commentary on Twitter

 


[Preprint] Early Safety Indicators of COVID-19 Convalescent Plasma in 5,000 Patients

15 May, 2020 | 03:50h | UTC

Early Safety Indicators of COVID-19 Convalescent Plasma in 5,000 Patients – medRxiv

Commentary: Convalescent plasma is safe to treat COVID-19: nationwide study – NBC News

 


Systematic Review: Plasma from People who Have Recovered from COVID-19 to Treat Individuals with COVID-19

15 May, 2020 | 03:48h | UTC

Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a rapid review – Cochrane Library

Summary: Plasma from people who have recovered from COVID-19 to treat individuals with COVID-19 – Cochrane Library

 


Coagulation Abnormalities and Thrombosis in Patients with COVID-19

12 May, 2020 | 03:16h | UTC

Coagulation abnormalities and thrombosis in patients with COVID-19 – The Lancet

 

Related Commentary on Twitter

 


NCCN Guideline: Hematopoietic Cell Transplantation

10 May, 2020 | 23:53h | UTC

Hematopoietic Cell Transplantation, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology – Journal of the National Comprehensive Cancer Network

 


Autopsies Find High Incidence of Venous Thromboembolism in Patients with Covid-19

7 May, 2020 | 09:18h | UTC

Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study – Annal of Internal Medicine

Related Study: Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19 – Journal of Thrombosis and Haemostasis

 


Observational Study: Anticoagulation Linked to Increased Survival Among Hospitalized Patients with COVID-19

7 May, 2020 | 09:16h | UTC

Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 – Journal of the American College of Cardiology

Commentaries: Giving blood thinners to severely ill Covid-19 patients is gaining ground – STAT AND Blood thinners may improve survival among hospitalized COVID-19 patients – Mount Sinai Hospital AND Anticoagulation Associated With Improved Outcomes in Hospitalized COVID-19 Patients – American College of Cardiology AND Expert reaction to study looking at blood thinners in hospitalised patients with COVID-19 – Science Media Centre

 


Case Reports: Acute Limb Ischemia in Two Young Patients with COVID-19

7 May, 2020 | 09:15h | UTC

Acute limb ischaemia in two young, non-atherosclerotic patients with COVID-19 – The Lancet

 


Despite Anticoagulation, Patients with Severe SARS-CoV-2 Infection are at Increased Risk of Developing Thrombosis

6 May, 2020 | 03:40h | UTC

High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study – Intensive Care Medicine

 


Meta-Analysis: Effects of Restrictive vs. Liberal Transfusion Strategies on Longer-term Outcomes After Cardiac Surgery

5 May, 2020 | 03:54h | UTC

The effect of restrictive versus liberal transfusion strategies on longer-term outcomes after cardiac surgery: a systematic review and meta-analysis with trial sequential analysis – Canadian Journal of Anesthesia

Related: Randomized Trial: In Patients Undergoing Cardiac Surgery, A Restrictive Transfusion Approach Does Not Increase the Risk of Acute Kidney Injury (selection of studies on the subject)

 


Short Review: Coagulopathy Associated with COVID-19

3 May, 2020 | 22:09h | UTC

Coagulopathy associated with COVID-19 – Canadian Medical Association Journal

 


Small Observational Study Suggests Prophylactic LMWH Can Prevent COVID‐19 Disseminated Intravascular Coagulopathy

1 May, 2020 | 03:26h | UTC

COVID‐19 Coagulopathy in Caucasian patients – British Journal of Haematology

Commentary: Blood clotting a significant cause of death in patients with COVID-19 – RCSI University of Medicine and Health Sciences

 


COVID-19 and Its Implications for Thrombosis and Anticoagulation

30 Apr, 2020 | 04:13h | UTC

COVID-19 and its implications for thrombosis and anticoagulation – Blood

 


Report: Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19

28 Apr, 2020 | 04:45h | UTC

Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands – Radiology

 


[Abstract Only] Randomized Trial: Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease

23 Apr, 2020 | 09:14h | UTC

Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease – New England Journal of Medicine

 


WHO Guideline on Use of Ferritin to Assess Iron Status in Individuals and Populations

22 Apr, 2020 | 08:38h | UTC

WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations – World Health Organization

News Release: WHO guidance helps detect iron deficiency and protect brain development

 


D‐dimer Levels on Admission to Predict In‐hospital Mortality in Patients with Covid‐19

21 Apr, 2020 | 08:06h | UTC

D‐dimer levels on admission to predict in‐hospital mortality in patients with Covid‐19 – Journal of Thrombosis and Haemostasis

Related: D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis – Thrombosis and Haemostasis

 


Thrombocytopenia and Its Association with Mortality in Patients with COVID‐19

21 Apr, 2020 | 08:04h | UTC

Thrombocytopenia and Its Association with Mortality in Patients with COVID‐19 – Journal of Thrombosis and Haemostasis

Related: Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis – Clinica Chimica Acta

 


Review: COVID-19 and Thrombotic or Thromboembolic Disease

20 Apr, 2020 | 00:18h | UTC

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up – Journal of the American College of Cardiology

Commentary: JACC Paper Outlines Implications, Considerations For Thrombotic Disease Patients During COVID-19 Pandemic – American College of Cardiology

 


Pathological Evidence of Pulmonary Thrombotic Phenomena in Severe COVID-19

17 Apr, 2020 | 02:24h | UTC

Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19 – Journal of Thrombosis and Haemostasis

* We congratulate the authors for this significant contribution to the understanding of this disease.

 


Review: Hematological Findings and Complications of COVID‐19

16 Apr, 2020 | 02:40h | UTC

Hematological findings and complications of COVID‐19 – American Journal of Hematology